title: Immunization against SIVmne in macaques using multigenic DNA vaccines.
abstract: All structural and regulatory genes of SIVmne were cloned into mammalian expression vectors to optimize expression in vitro and immunogenicity in mice. Macaca fascicularis were immunized four times with plasmid DNA (n = 4), or two DNA priming inoculations followed by two boosts of recombinant gp160 plus Gag-Pol particles (n = 4). Following intrarectal challenge with SIVmne, all macaques became infected. Three monkeys immunized with DNA alone maintained low plasma virus loads by 1 year post-challenge; the fourth exhibited high virus loads and significant CD4+ cell decline. Two of the DNA plus boost and three control macaques had high virus loads and associated CD4+ cell decline. Both vaccine protocols elicited antibodies and comparable helper T-cell proliferative responses to gp160. Cytokine mRNA levels in activated peripheral blood mononuclear cells (PBMC) taken at time of challenge suggested a dominant T helper (Th) 1 state in three DNA-immunized and one protein-boosted macaque, which correlated with low virus loads and high CD4+ cell counts post-challenge.
authors.affiliation: Seattle Biomedical Research Institute, WA 98109-1651, USA.
authors.forename: S P
authors.initials: SP
authors.lastname: Mossman
authors.forename: C C
authors.initials: CC
authors.lastname: Pierce
authors.forename: M N
authors.initials: MN
authors.lastname: Robertson
authors.forename: A J
authors.initials: AJ
authors.lastname: Watson
authors.forename: D C
authors.initials: DC
authors.lastname: Montefiori
authors.forename: M
authors.initials: M
authors.lastname: Rabin
authors.forename: L
authors.initials: L
authors.lastname: Kuller
authors.forename: J
authors.initials: J
authors.lastname: Thompson
authors.forename: J B
authors.initials: JB
authors.lastname: Lynch
authors.forename: W R
authors.initials: WR
authors.lastname: Morton
authors.forename: R E
authors.initials: RE
authors.lastname: Benveniste
authors.forename: R
authors.initials: R
authors.lastname: Munn
authors.forename: S L
authors.initials: SL
authors.lastname: Hu
authors.forename: P
authors.initials: P
authors.lastname: Greenberg
authors.forename: N L
authors.initials: NL
authors.lastname: Haigwood
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D018791:CD4 Lymphocyte Count; D003001:Cloning, Molecular; D004279:DNA, Viral / Q000276:immunology*; D015685:Fusion Proteins, gag-pol / Q000235:genetics / Q000276:immunology; D005822:Genetic Vectors; D019302:HIV Envelope Protein gp160 / Q000235:genetics / Q000276:immunology; D007114:Immunization / Q000662:veterinary; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014613:Vaccines, Attenuated / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology*; D019562:Viral Load
chemical_list: D016915:AIDS Vaccines; D004279:DNA, Viral; D015685:Fusion Proteins, gag-pol; D019302:HIV Envelope Protein gp160; D014613:Vaccines, Attenuated; D019444:Vaccines, DNA